A 28-year-old woman from Mumbai with a 2-year history of Graves disease, currently on propranolol and methimazole, presents with palpitations, tremor, and anxiety despite medication. TSH is <0.01 mIU/L, free T4 is 3.2 ng/dL (normal 0.8–1.8), and free T3 is 8.5 pg/mL (normal 2.3–4.2). She is afebrile with no neck tenderness. What is the most appropriate next step in management?

Explanation

## Clinical Scenario: Inadequately Controlled Hyperthyroidism The patient has **persistent thyrotoxicosis** despite antithyroid therapy: - Symptoms: palpitations, tremor, anxiety (signs of excess thyroid hormone) - Laboratory: suppressed TSH, elevated free T4 and free T3 - Afebrile, no neck tenderness → **NOT thyroid storm or thyroiditis** ### Why Increase Methimazole + Add Iodine **Key Point:** In inadequately controlled Graves disease on antithyroid drugs, the first step is to optimize antithyroid therapy by increasing the dose of the current agent and adding iodine to rapidly block thyroid hormone release. ### Mechanism of Action Comparison | Agent | Mechanism | Onset | Use Case | |-------|-----------|-------|----------| | Methimazole | PTU-like: inhibits TPO (hormone synthesis) | 1–2 weeks | Maintenance therapy | | Iodine (Lugol's) | Blocks thyroid hormone release from gland | 24–48 hours | Acute control, pre-operative | | Propranolol | β-blocker: symptomatic relief | Hours | Palpitations, tremor | **High-Yield:** The combination of **increased methimazole + iodine** provides: 1. Enhanced synthesis inhibition (higher methimazole dose) 2. Rapid release blockade (iodine acts within 1–2 days) 3. Symptom relief (propranolol already in place) **Clinical Pearl:** Iodine should ONLY be added AFTER antithyroid drugs are started. If given first, it may paradoxically worsen hyperthyroidism by providing substrate for hormone synthesis (Jod-Basedow phenomenon). ### Dosing Strategy ```mermaid flowchart TD A[Inadequate control on current methimazole]:::outcome A --> B[Increase methimazole to 30-40 mg daily]:::action B --> C[Add Lugol's iodine 5-7 drops TDS]:::action C --> D[Recheck free T4/T3 in 1-2 weeks]:::decision D -->|Controlled| E[Taper iodine, continue methimazole]:::action D -->|Uncontrolled| F[Consider definitive therapy: RAI or surgery]:::action ``` ### Why Other Options Are Incorrect **Option 1 (Switch to PTU):** PTU is reserved for: - Methimazole-induced agranulocytosis or hepatotoxicity - First trimester pregnancy (lower teratogenicity) - Thyroid storm (minor additional benefit over methimazole) Simple inadequate control is NOT an indication to switch; increasing the current dose is more rational. **Option 2 (Imaging + TRAb):** These are diagnostic tests, not therapeutic interventions. While TRAb may predict remission risk, they do NOT address acute thyrotoxicosis. Imaging is unnecessary unless nodules or malignancy is suspected. **Option 3 (Plasmapheresis + emergency surgery):** These are reserved for **thyroid storm** (fever, altered mental status, severe cardiovascular instability). This patient is afebrile and hemodynamically compensated on beta-blockers. Plasmapheresis is rarely used and only in life-threatening thyroid storm unresponsive to medical therapy. **Mnemonic:** **IODINE AFTER DRUGS** — Never give iodine alone or before antithyroid drugs in Graves disease. [cite:Harrison 21e Ch 405; Endocrinology (Melmed et al.) Ch 12]